Global Impetigo Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Impetigo Treatment
    1.2 Classification of Impetigo Treatment by Type
        1.2.1 Overview: Global Impetigo Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Impetigo Treatment Revenue Market Share by Type in 2020
        1.2.3 Cephalosporins
        1.2.4 Fusidane
        1.2.5 Lincosamide Antibiotic
        1.2.6 Penicillin
        1.2.7 Penicillin-Like Antibiotics
        1.2.8 Pleuromutilin
        1.2.9 Pseudomonic Acid A
        1.2.10 Quinolone
        1.2.11 Sulfonamides And Folic Acid Inhibitors
        1.2.12 Tetracyclines
    1.3 Global Impetigo Treatment Market by Application
        1.3.1 Overview: Global Impetigo Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Impetigo Treatment Market Size & Forecast
    1.5 Global Impetigo Treatment Market Size and Forecast by Region
        1.5.1 Global Impetigo Treatment Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Impetigo Treatment Market Size by Region, (2016-2021)
        1.5.3 North America Impetigo Treatment Market Size and Prospect (2016-2026)
        1.5.4 Europe Impetigo Treatment Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Impetigo Treatment Market Size and Prospect (2016-2026)
        1.5.6 South America Impetigo Treatment Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Impetigo Treatment Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Impetigo Treatment Market Drivers
        1.6.2 Impetigo Treatment Market Restraints
        1.6.3 Impetigo Treatment Trends Analysis
2 Company Profiles
    2.1 GlaxoSmithKline plc
        2.1.1 GlaxoSmithKline plc Details
        2.1.2 GlaxoSmithKline plc Major Business
        2.1.3 GlaxoSmithKline plc Impetigo Treatment Product and Solutions
        2.1.4 GlaxoSmithKline plc Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 GlaxoSmithKline plc Recent Developments and Future Plans
    2.2 Karalex Pharma, LLC
        2.2.1 Karalex Pharma, LLC Details
        2.2.2 Karalex Pharma, LLC Major Business
        2.2.3 Karalex Pharma, LLC Impetigo Treatment Product and Solutions
        2.2.4 Karalex Pharma, LLC Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Karalex Pharma, LLC Recent Developments and Future Plans
    2.3 Leo Pharma A/S
        2.3.1 Leo Pharma A/S Details
        2.3.2 Leo Pharma A/S Major Business
        2.3.3 Leo Pharma A/S Impetigo Treatment Product and Solutions
        2.3.4 Leo Pharma A/S Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Leo Pharma A/S Recent Developments and Future Plans
    2.4 Lupin Limited
        2.4.1 Lupin Limited Details
        2.4.2 Lupin Limited Major Business
        2.4.3 Lupin Limited Impetigo Treatment Product and Solutions
        2.4.4 Lupin Limited Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Lupin Limited Recent Developments and Future Plans
    2.5 NovaBay Pharmaceuticals, Inc.
        2.5.1 NovaBay Pharmaceuticals, Inc. Details
        2.5.2 NovaBay Pharmaceuticals, Inc. Major Business
        2.5.3 NovaBay Pharmaceuticals, Inc. Impetigo Treatment Product and Solutions
        2.5.4 NovaBay Pharmaceuticals, Inc. Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 NovaBay Pharmaceuticals, Inc. Recent Developments and Future Plans
    2.6 Pfizer, Inc.
        2.6.1 Pfizer, Inc. Details
        2.6.2 Pfizer, Inc. Major Business
        2.6.3 Pfizer, Inc. Impetigo Treatment Product and Solutions
        2.6.4 Pfizer, Inc. Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Pfizer, Inc. Recent Developments and Future Plans
    2.7 Ranbaxy Laboratories Limited
        2.7.1 Ranbaxy Laboratories Limited Details
        2.7.2 Ranbaxy Laboratories Limited Major Business
        2.7.3 Ranbaxy Laboratories Limited Impetigo Treatment Product and Solutions
        2.7.4 Ranbaxy Laboratories Limited Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Ranbaxy Laboratories Limited Recent Developments and Future Plans
    2.8 Roche Holding AG
        2.8.1 Roche Holding AG Details
        2.8.2 Roche Holding AG Major Business
        2.8.3 Roche Holding AG Impetigo Treatment Product and Solutions
        2.8.4 Roche Holding AG Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Roche Holding AG Recent Developments and Future Plans
    2.9 SANDOZ GmbH
        2.9.1 SANDOZ GmbH Details
        2.9.2 SANDOZ GmbH Major Business
        2.9.3 SANDOZ GmbH Impetigo Treatment Product and Solutions
        2.9.4 SANDOZ GmbH Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 SANDOZ GmbH Recent Developments and Future Plans
    2.10 Taro Pharmaceutical Industries Ltd 
        2.10.1 Taro Pharmaceutical Industries Ltd Details
        2.10.2 Taro Pharmaceutical Industries Ltd Major Business
        2.10.3 Taro Pharmaceutical Industries Ltd Impetigo Treatment Product and Solutions
        2.10.4 Taro Pharmaceutical Industries Ltd Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Taro Pharmaceutical Industries Ltd Recent Developments and Future Plans
    2.11 Teva Pharmaceutical Industries Ltd
        2.11.1 Teva Pharmaceutical Industries Ltd Details
        2.11.2 Teva Pharmaceutical Industries Ltd Major Business
        2.11.3 Teva Pharmaceutical Industries Ltd Impetigo Treatment Product and Solutions
        2.11.4 Teva Pharmaceutical Industries Ltd Impetigo Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Impetigo Treatment Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Impetigo Treatment Players Market Share
        3.2.2 Top 10 Impetigo Treatment Players Market Share
        3.2.3 Market Competition Trend
    3.3 Impetigo Treatment Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Impetigo Treatment Revenue and Market Share by Type (2016-2021)
    4.2 Global Impetigo Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Impetigo Treatment Revenue Market Share by Application (2016-2021)
    5.2 Impetigo Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Impetigo Treatment Revenue by Type (2016-2026)
    6.2 North America Impetigo Treatment Revenue by Application (2016-2026)
    6.3 North America Impetigo Treatment Market Size by Country
        6.3.1 North America Impetigo Treatment Revenue by Country (2016-2026)
        6.3.2 United States Impetigo Treatment Market Size and Forecast (2016-2026)
        6.3.3 Canada Impetigo Treatment Market Size and Forecast (2016-2026)
        6.3.4 Mexico Impetigo Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Impetigo Treatment Revenue by Type (2016-2026)
    7.2 Europe Impetigo Treatment Revenue by Application (2016-2026)
    7.3 Europe Impetigo Treatment Market Size by Country
        7.3.1 Europe Impetigo Treatment Revenue by Country (2016-2026)
        7.3.2 Germany Impetigo Treatment Market Size and Forecast (2016-2026)
        7.3.3 France Impetigo Treatment Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Impetigo Treatment Market Size and Forecast (2016-2026)
        7.3.5 Russia Impetigo Treatment Market Size and Forecast (2016-2026)
        7.3.6 Italy Impetigo Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Impetigo Treatment Revenue by Type (2016-2026)
    8.2 Asia-Pacific Impetigo Treatment Revenue by Application (2016-2026)
    8.3 Asia-Pacific Impetigo Treatment Market Size by Region
        8.3.1 Asia-Pacific Impetigo Treatment Revenue by Region (2016-2026)
        8.3.2 China Impetigo Treatment Market Size and Forecast (2016-2026)
        8.3.3 Japan Impetigo Treatment Market Size and Forecast (2016-2026)
        8.3.4 South Korea Impetigo Treatment Market Size and Forecast (2016-2026)
        8.3.5 India Impetigo Treatment Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Impetigo Treatment Market Size and Forecast (2016-2026)
        8.3.7 Australia Impetigo Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Impetigo Treatment Revenue by Type (2016-2026)
    9.2 South America Impetigo Treatment Revenue by Application (2016-2026)
    9.3 South America Impetigo Treatment Market Size by Country
        9.3.1 South America Impetigo Treatment Revenue by Country (2016-2026)
        9.3.2 Brazil Impetigo Treatment Market Size and Forecast (2016-2026)
        9.3.3 Argentina Impetigo Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Impetigo Treatment Revenue by Type (2016-2026)
    10.2 Middle East & Africa Impetigo Treatment Revenue by Application (2016-2026)
    10.3 Middle East & Africa Impetigo Treatment Market Size by Country
        10.3.1 Middle East & Africa Impetigo Treatment Revenue by Country (2016-2026)
        10.3.2 Turkey Impetigo Treatment Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Impetigo Treatment Market Size and Forecast (2016-2026)
        10.3.4 UAE Impetigo Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer